| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.28M | 10.20M | 10.82M | 10.45M | 10.14M | 10.18M |
| Gross Profit | 5.17M | 4.93M | 5.40M | 4.69M | 4.66M | 4.44M |
| EBITDA | 2.47M | 1.88M | 2.34M | 1.93M | 1.39M | 903.00K |
| Net Income | 1.88M | 1.28M | 2.30M | 1.76M | 1.80M | 449.00K |
Balance Sheet | ||||||
| Total Assets | 9.38M | 9.57M | 9.24M | 8.63M | 9.30M | 8.39M |
| Cash, Cash Equivalents and Short-Term Investments | 3.92M | 3.62M | 2.68M | 2.38M | 3.01M | 2.32M |
| Total Debt | 0.00 | 0.00 | 0.00 | 192.00K | 450.00K | 871.00K |
| Total Liabilities | 2.59M | 3.15M | 3.58M | 4.86M | 4.58M | 4.82M |
| Stockholders Equity | 6.80M | 6.42M | 5.66M | 3.77M | 4.72M | 3.57M |
Cash Flow | ||||||
| Free Cash Flow | 1.91M | 1.57M | 1.05M | 2.38M | 1.86M | 586.00K |
| Operating Cash Flow | 2.02M | 1.65M | 1.13M | 2.42M | 1.98M | 786.00K |
| Investing Cash Flow | -112.00K | -84.00K | -80.00K | -45.00K | -119.00K | -200.00K |
| Financing Cash Flow | -1.00M | -625.00K | -754.00K | -3.00M | -1.18M | -865.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £14.98M | 2.03 | 28.74% | 5.18% | ― | ― | |
67 Neutral | £142.53M | 11.95 | 8.80% | 1.68% | 6.27% | 0.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | £36.73M | -9.99 | 8.83% | 2.44% | -25.63% | -20.36% | |
51 Neutral | £4.43M | -22.52 | 0.89% | ― | ― | ― | |
47 Neutral | £59.66M | -3.17 | -17.65% | ― | -1.09% | -6.65% | |
46 Neutral | £36.75M | -28.61 | 49.22% | ― | 1.73% | -68.87% |